Beneath the Surface

In this episode, guest Adewole S. Adamson, MD, MPP, discusses use of sunscreen, outlines how to decipher labels and debunks myths surrounding sunscreen. ·       Who should wear sunscreen, and when should they put it on? 1:16 ·       What ingredients should consumers look for on a sunscreen label? 5:37 ·       How can you differentiate between chemical and physical sunscreens? 7:27 ·       What are the current and upcoming innovations in sunscreens? 8:34 ·       What are some myths and controversies surrounding sunscreen? 9:44 ·       What excites you about sunscreen now? 16:13 For more, be sure to visit the Beneath the Surface video blog on Healio.com. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at [email protected]. Follow Dr. Gelfand on LinkedIn. Dr. Adamson can be reached at [email protected] or on Instagram @adeadamsonmd. Gelfand is Chief Medical Editor of Healio Dermatology. Adamson reports no relevant financial disclosures.

In this episode, guest Joseph F. Merola, MD, discusses the results of the TOGETHER-PsA trial and explores combination therapy as an integrated approach to psoriatic arthritis (PsA) management. ·       What is the role of obesity in PsA?  0:55 ·       Dr. Merola discusses findings from the TOGETHER-PsA trial. 2:11 ·       Is the difference clinically meaningful to you as a rheumatologist? 4:16 ·       For patients today, would you combine tirzepatide with ixekizumab as a form of standard care? 5:13 Joseph Merola, MD, MMSc, is professor and chair of the department of dermatology, professor of internal medicine in the division of rheumatic diseases and professor in the UT Southwestern O'Donnell School of Public Health. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at [email protected]. Follow Dr. Gelfand on LinkedIn. Dr. Merola can be reached at [email protected]. For more, be sure to visit the Beneath the Surface video blog on Healio.com. Disclosures: Eli Lilly sponsored TOGETHER-PsA. Gelfand is Chief Medical Editor of Healio Dermatology. Merola reports receiving consultant fees from AbbVie, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly, Incyte, Janssen, Leo Pharma, MoonLake Immunotherapeutics, Novartis, Pfizer, Sanofi-Regeneron and UCB; and grant or research support from Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly, Janssen, MoonLake Immunotherapeutics, Sanofi-Regeneron, Sun Pharma and UCB. References: ·        Merola JF, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70134. ·        Merola JF, et al. Late-breaking research: Session 2. Presented at: American Academy of Dermatology Annual Meeting; March 27-31, 2026; Denver.

In this episode, guest Robert Kirsner, MD, PhD, discusses clinical approaches to diagnosing chronic wounds, advancements and methods for treating them. ·       Intro 0:28 ·       Robert Kirsner, MD, PhD 0:35 ·       From a public health perspective, how big of a problem are chronic wounds?  0:59 ·       What is your clinical approach to define and evaluate chronic wounds? 2:06 ·       What imaging do you order for patients with lower extremity wounds? 4:58 ·       What advancements are we seeing in wound healing? 6:46 ·       What are some of the differential diagnoses that can generate chronic wounds in patients? 8:25 ·       Can you describe your technique for biopsy? 9:37 ·       Are there situations where you should avoid biopsy? 10:27 ·       Does a diagnosis of exclusion such as pyoderma gangrenosum (PG) need to be biopsied? 11:30 ·       Are retinoids like acitretin commonly used? 11:39 ·       What is your approach to patients with PG? 12:30 ·       Are there other immune targets that you're excited about for PG? 14:28 ·       Thanks for listening. 15:29 Robert Kirsner, MD, PhD, is chairman and professor in the department of dermatology and cutaneous surgery at University of Miami Miller School of Medicine, director of the University of Miami Hospital and Clinics Wound Center and a past vice president of the American Academy of Dermatology. We'd love to hear from you! Send your comments/questions to Dr. Gelfand at [email protected]. Follow Dr. Gelfand on LinkedIn. Dr. Kirsner can be reached at [email protected]. For more, be sure to visit the Beneath the Surface video blog on Healio.com. Disclosures: Gelfand is Chief Medical Editor of Healio Dermatology. Kirsner reports receiving advisory board or consultant fees from AbbVie, BPGbio, Kerecis, Leo Pharma, Organogenesis, Smith & Nephew and Urgo and grant or research support from Boehringer Ingelheim and MediWound. References: ·        Pyoderma gangrenosum. https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg. Updated May 13, 2022. Accessed Feb. 25, 2026.